Notice of Proposed Sale · 144
CAMP4 Therapeutics Corporation
CAMPNASDAQEQUITYCurrent
Notice of Proposed Sale
Structured filing — 144
primary_doc.xml
Notice of proposed sale. The proposed amounts below do not establish that a sale occurred.
Proposed-sale notice
- Issuer
- CAMP4 Therapeutics Corporation
- Issuer CIK
- 0001736730
- SEC file number
- 001-42365
- Phone
- 6176518867
- Person for whose account securities are to be sold
- Daniel Tardiff
- Relationships to issuer
- affiliate
- Street
- 100 Talcott Avenue
- Street (continued)
- Suite 201
- City
- Watertown
- State / country code
- MA
- Postal code
- 02472
Securities proposed for sale
| Security | Proposed units | Aggregate market value | Units outstanding | Approximate sale date | Exchange | Broker / market maker |
|---|---|---|---|---|---|---|
| Common Stock | 1,738 | 8,275.55 | 51,925,800 | 08/19/2026 | NASDAQ | J.P. Morgan Securities LLC |
Broker / market maker — proposed row 1, entry 1
- Name
- J.P. Morgan Securities LLC
- Street
- 270 Park Ave
- Street (continued)
- 10th Floor
- City
- New York
- State / country code
- NY
- Postal code
- 10017
Acquisition of securities to be sold
| Security | Acquired | Nature of acquisition | Acquired from | Amount acquired | Gift transaction | Payment date | Nature of payment |
|---|---|---|---|---|---|---|---|
| Common | 07/02/2026 | 434 ESPP Issuance | Camp4 Therapeutics | 1,738 | N | 07/02/2026 | cash |
Prior-sale reporting
- Nothing to report for the preceding three months
- Y
Notice signature
- Notice date
- 08/19/2026
- Signed
- J.P. Morgan Securities LLC, Workplace Solutions, as Agent and Attorney in Fact for Daniel Tardiff, CAMP4 Therapeutics